Navigation Links
The Zacks Analyst Blog Highlights: Eaton, Baxter International, Bio-Rad Laboratories, INSYS Therapeutics and Boston Scientific
Date:10/25/2013

SE: BAX-Free Report) declared the commercial launch of HEMOPATCH Sealing Hemostat, following CE mark approval in Europe. The development of this new collagen-based hemostatic device showcases the strong expertise of the company in collagen, internal coagulation processes and PEG (polyethylene glycol) technology platforms.

The HEMOPATCH is an important addition to Baxter's BioSurgery product portfolio, which consists of a range of biological and synthetic products and delivery devices used for hemostasis, tissue sealing, adhesion reduction, hard tissue regeneration, as well as soft tissue repair and microsurgery products.

Hemostasis is a physiological process which stops bleeding resulting from a cut or injury. Bleeding in surgical procedures is a major problem encountered by all surgeons. Complications from excessive bleeding may include blood loss, tissue damage, infection and excessive scarring. If uncontrolled, it can even turn out to be life-threatening.

Baxter's HEMOPATCH will provide a unique solution to this problem. It is a resorbable hemostatic device effectively designed to stop bleeding in surgical situations where other conventional methods often fail.

The thin, soft and flexible collagen pad allows surgeons to attain rapid hemostasis, as it firmly adheres to the bleeding tissue surface. Further, the specially-formulated porous collagen matrix, covered on one side with a thin protein bonding layer, known as NHS-PEG, helps to seal off the bleeding surface, initiating the body's own clotting process.

The new surgical tool promises to be a boon for surgeons. It is quick and effective, requires zero preparation time, and can be applied to varied surgical settings. Preclinical testing has also guaranteed the product's hemos
'/>"/>
SOURCE Zacks Investment Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. The Zacks Analyst Blog Highlights: SPDR Health Care Select Sector Fund, SPDR S&P 500, SPDRS&P Biotech ETF, PowerShares S&P SmallCap Health Care Portfolio and PowerShares Dynamic Biotechnology & Genome Portfolio
2. Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index Fund
3. S&P Capital IQ to Share Its Views on the Biotech Bull Market During the Next "ETF Analyst Hour"
4. Rising Concerns Over Food Safety Drives Demand for Agricultural and Environmental Diagnostics, According to New Report by Global Industry Analysts, Inc.
5. Technology Developments Drive Growth in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Market, According to New Report by Global Industry Analysts, Inc.
6. Rising Interest in Molecular Biology Research Drives Demand for qPCR and dPCR Instrumentation, According to a Soon to be Released Report by Global Industry Analysts, Inc.
7. Increasing Need for Supply of High-Quality Water Drives Growth in the Water Analysis Instrumentation Market, According to New Report by Global Industry Analysts, Inc.
8. Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
9. Legislative Benefits and Unmet Needs to Drive the Market for Orphan Drugs, According to a New Report by Global Industry Analysts, Inc.
10. Rising Incidence of Stroke Drives the Global Intracranial Stents Market, According to New Report by Global Industry Analysts, Inc.
11. Global H1N1 Vaccines Market to Reach US $273 Million by 2018, According to a New Report by Global Industry Analysts, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015 Trimb Healthcare AB ("Trimb") ... acquire YouMedical Group BV ("YouMedical"), a Dutch OTC company ... annual sales of approximately EUR 16 million, with solid ... "Our ambition is to build a leading international ... toward that goal. YouMedical gives us a stronger North ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option for excessive ... commercially available new FDA approved system in the last 14 years, and the only ... Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, and ...
(Date:8/28/2015)... 2015 Research and Markets ... "Global & USA BioSimilar Market Analysis to 2021" ... awaited US Biosimilar market will be initiated in September ... How will the global market react? Will biosimilars explode ... could save the US economy up to $250 billion ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... has organized and will present a session on chemical spectroscopic imaging at JASIS ... and exposition is Asia’s largest analytical and scientific instruments show which will be ...
Breaking Biology Technology:U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 2U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 3
... YORK, June 18 Danube Pharmaceuticals, Inc., a,privately ... development of innovative drugs for ophthalmology, is pleased,to ... MBA as its Chief,Executive Officer., "I am ... this,inflection point in its history as it advances ...
... CHESHIRE, Conn., June 18 Alexion,Pharmaceuticals, Inc. (Nasdaq: ... Officer of Alexion Pharmaceuticals, will present at the,Jefferies & ... at 4:15,p.m., ET on Wednesday, June 25, 2008., ... available live. You can,access the webcast at: http://www.alexionpharm.com ...
... N.J., June 18 HemoCue(R) AB, a,global point-of-care ... Diagnostics Incorporated (NYSE: DGX ), today announced,that ... quantitative point-of-care,test for screening for, diagnosing and monitoring ... U.S. Food and Drug Administration (FDA). With,the FDA ...
Cached Biology Technology:Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 2Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 3HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 2HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 3HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 4HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 5
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions , ... entire spectrum of clinical research, is proud to announce ... company,s comprehensive SaaS-based eClinical technology platform, has led the ... first two quarters of 2015.   Q2 2015 and ... quarters measured by contract value sold in the company,s ...
(Date:8/11/2015)... , August 11, 2015 Today, ZUK ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
(Date:8/6/2015)... , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking Integration ... Moverio BT-200 see-through head mounted display and on SMI,s ... quality and efficiency is brought to personalized visualization and ... first time, professionals and researchers can integrate gaze, and ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... milk can kill cancer cells, reveal studies carried out by ... Although the special substance, known as HAMLET (Human ... milk several years ago, it is only now that it ... cancer of the bladder who were treated with the substance ...
... a new species of dinosaur with a softball-sized lump of ... paper published in the April issue of the journal ... dinosaur about as big as a medium-sized dog that lived ... Yale University, lead author of the paper. The team discovered ...
... TALLAHASSEE, Fla. - Imagine the marriage of hard metals or ... wonderful offspring hybrid materials never conceived by Mother Nature. ... says biologist Steven Lenhert, the newest faculty face of nanoscience ... mobile phone fitted with a "lab on a chip" that ...
Cached Biology News:New bony-skulled dinosaur species discovered in Texas 2Bionanotechnology has new face, world-class future at Florida State 2Bionanotechnology has new face, world-class future at Florida State 3
... Hitachi Innovative Linear Ion Trap Time of Flight Mass Analyzer for ... mode measurement range: 100 - 25,000 m/z, * Precursor ion selection ... over, * MS accuracy: 5 ppm with internal reference, * Dynamic ... ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
Mouse polyclonal antibody to BTAF1 - BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)...
... series combines Harvard Apparatuss best pump mechanism, a ... range of configuration options. A lookup table in ... from all the major manufacturers. A bright, two ... information from across the lab. All models have ...
Biology Products: